Laskin, Janessa
BC Cancer Agency
4 papers on CoChatORCID 0000-0002-0161-9329
Most cited papers
- Verified
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Park, K., Tan, E.-H., O'Byrne, K., Zhang, L., Boyer, M., Mok, T., Hirsh, V., Yang, J. C.-H., Lee, K. H., Lu, S., et al. (2016) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 1,183
- Verified
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Chan-Seng-Yue, M., Kim, J. C., Wilson, G. W., Ng, K., Figueroa, E. F., O’Kane, G. M., Connor, A. A., Denroche, R. E., Grant, R. C., McLeod, J., et al. (2020) · Nature Genetics
Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics
Cited by 669
- Verified
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
Paz-Ares, L., Tan, E.-H., O’Byrne, K., Zhang, L., Hirsh, V., Boyer, M., Yang, J. C.-H., Mok, T., Lee, K. H., Lu, S., et al. (2017) · Annals of Oncology
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 524
- Verified
Application of a neural network whole transcriptome-based pan-cancer method for diagnosis of primary and metastatic cancers
Grewal, J. K., Tessier-Cloutier, B., Jones, M., Gakkhar, S., Ma, Y., Moore, R., Mungall, A. J., Zhao, Y., Taylor, M. D., Gelmon, K., et al. (2019) · JAMA Network Open
Cancer Diagnosis and TreatmentGene expression and cancer classification
Cited by 90
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free